MGEA5 Antikörper (AA 380-580)
Kurzübersicht für MGEA5 Antikörper (AA 380-580) (ABIN6143821)
Target
Alle MGEA5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 380-580
-
Sequenz
- YQEPIMSQGA ALSGEPTTLT KEEEKKQPDE EPMDMVVEKQ EETDHKNDNQ ILSEIVEAKM AEELKPMDTD KESIAESKSP EMSMQEDCIS DIAPMQTDEQ TNKEQFVPGP NEKPLYTAEP VTLEDLQLLA DLFYLPYEHG PKGAQMLREF QWLRANSSVV SVNCKGKDSE KIEEWRSRAA KFEEMCGLVM GMFTRLSNCA N
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 380-580 of human MGEA5 (NP_001135906.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:200 - 1:2000,IHC,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- MGEA5 (Meningioma Expressed Antigen 5 (Hyaluronidase) (MGEA5))
-
Andere Bezeichnung
- MGEA5
-
Hintergrund
- The dynamic modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) addition and removal on serine and threonine residues is catalyzed by OGT (MIM 300255), which adds O-GlcNAc, and MGEA5, a glycosidase that removes O-GlcNAc modifications (Gao et al., 2001 [PubMed 11148210]).[supplied by OMIM, Mar 2008],MGEA5,MEA5,NCOAT,OGA,Cancer,Tumor immunology,MGEA5
-
Molekulargewicht
- 76 kDa/95 kDa/96 kDa/102 kDa
-
Gen-ID
- 10724
-
UniProt
- O60502
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Regulation of Carbohydrate Metabolic Process
Target
-